cxcl1 (R&D Systems)
Structured Review

Cxcl1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 165 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cxcl1/Mouse+CXCL1%2FKC+Quantikine+ELISA+Kit/pmc12859453-607-14-15
Average 95 stars, based on 165 article reviews
Images
1) Product Images from "Sulfated polysaccharide prevents senescent adipocyte-driven osteonecrosis by stem cell fate reprogramming"
Article Title: Sulfated polysaccharide prevents senescent adipocyte-driven osteonecrosis by stem cell fate reprogramming
Journal: Bioactive Materials
doi: 10.1016/j.bioactmat.2025.11.039
Figure Legend Snippet: SCS suppresses senescence cascade amplification by attenuating secondary spread from GC-induced primary senescent adipocytes. ( A ) Schematic illustration of SCS intervention exclusively during the fully developed senescent phase of MPS-induced bone marrow. ( B ) qPCR analysis of senescence-associated markers ( Cdkn1b , Cdkn1a , and Cdkn2c ) in bone tissues at 4 weeks following combined SCS and MPS treatment. n = 3 biological replicates. ( C ) ELISA analysis of bone marrow senescence-associated factors (IL-1β, IL-18, TNF-α, IL-6, CXCL1, and CCL3) after 4 weeks of combined treatment with SCS and MPS. n = 4 biological replicates. ( D ) Quantification of the maximal compressive load of the isolated distal femur and femoral diaphysis. n = 6 biological replicates. ( E ) Schematic diagram depicting isolation of bone marrow adipocytes from mice treated with SCS and MPS for 14 days using mature adipocyte-specific fast centrifugation and construction of a senescence propagation model in vitro . ( F and G ) Representative flow cytometry plots (D) and quantification (E) of EdU-positive (proliferating) CD45 − Ter119 − CD31 − LepR + MSCs cultured for 3 days with adipocyte conditioned medium (CM). n = 6 biological replicates. ( H and I ) Representative ALP staining images (F) and corresponding quantification of ALP activity (G) in CD45 − Ter119 − CD31 − LepR + MSCs cultured with SCS-induced adipocyte CM. n = 6 biological replicates. (Scale bars, 50 μm and 30 μm) ( J and K ) Representative Oil Red O staining (H) and quantification (I) of adipogenic differentiation in MSCs cultured with SCS-induced adipocyte CM. n = 6 biological replicates. (Scale bars, 50 μm and 25 μm) ( L and M ) Representative images (J) and quantification (K) of crystal violet-stained fibroblast colony-forming units (CFU-F) in MSCs cultured with various adipocyte CMs. n = 6 biological replicates. (Scale bars, 400 μm) ( N ) qPCR analysis of senescence-related markers ( Cdkn2a and Cdkn1a ) in MSCs treated with different adipocyte CMs. n = 3 biological replicates. ( O and P ) Representative immunofluorescence-FISH images (M) and quantification (N) showing colocalization of γ-H2A.X with telomere-associated foci (TAF) in MSCs cultured with different adipocyte CMs. n = 6 biological replicates. (Scale bars, 7 μm and 1 μm) ( Q and R ) Representative images (O) and quantification (P) of 2D tube formation assays in HUVECs cultured for 3 days with various adipocyte CMs. n = 6 biological replicates. (Scale bars, 100 μm and 25 μm) ( S and T ) Representative images (Q) and quantification (R) of SA-β-Gal–positive HUVECs (green) following 3-day treatment with different adipocyte CMs. n = 6 biological replicates. (Scale bars, 100 μm and 25 μm) ( U ) qPCR analysis of the senescence-related gene LMNB1 in HUVECs treated with various adipocyte CMs. n = 3 biological replicates. Data are presented as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; ns, not significant. Statistical significance was determined using an unpaired two-tailed Student's t -test ( B, C, D, G, I, K, M, N, R, T and U ).
Techniques Used: Amplification, Enzyme-linked Immunosorbent Assay, Isolation, Centrifugation, In Vitro, Flow Cytometry, Cell Culture, Staining, Activity Assay, Immunofluorescence, Two Tailed Test
Related Articles
other:Article Title: Senolytic‐Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers Article Snippet: 166 Er , CXCL1 , Article Title: A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload. Article Snippet: Enzyme-linked Immunosorbent Assay:Article Title: Montelukast suppresses NLRP3 inflammasome activation as a potential prophylactic agent against gout arthritis flares. Article Snippet: WT BMDM supernatants from the NLRC4/AIM2 inflammasome assays were evaluated for IL1β using the Mouse IL-1β/IL-1F2 DuoSet ELISA (R&D Systems, Cat. No. DY401) following manufacturer’s instructions. .. WT BMDM supernatants from the montelukast inflammation assays were evaluated for IL-6 using the Mouse IL-6 DuoSet ELISA (R&D Systems, Cat. No. DY406), TNF-α using the Mouse TNF-α DuoSet ELISA (R&D Systems, Cat. No. DY410), and CXCL1 using the Article Title: A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload Article Snippet: .. Actinomycin D (1229, R&D Systems), Healthy human PBMCs (Precision Medicine), HEK Blue Reporter Assay IL23 (hkb-il23, InvivoGen), HEK Blue Reporter Assay IL12 (hkb-il12, InvivoGen), L929 (Sigma), human IL23 (1290-IL/CF, R&D Systems), cynomolgus IL12 (10215-CL, R&D systems), human neutrophil elastase (324681, Merck), human TNF-α (TNFA-HA4211, Acro Bioscience), Phytohemagglutinin-L (PHA) (11249738001, Sigma), QUANTI-Blue solution (rep-qbs, InvivoGen), tofacitinib (FT32555, Biosynth), WST-1 reagent (11644807001, Merck), mIL-6 (Quantikine ELISA, M6000B, R&D Systems), MCP-1 (Quantikine ELISA, JE00B, R&D Systems), and Article Title: Montelukast suppresses NLRP3 inflammasome activation as a potential prophylactic agent against gout arthritis flares. Article Snippet: WT BMDM supernatants from the montelukast inflammation assays were evaluated for IL-6 using the Mouse IL-6 DuoSet ELISA (R&D Systems, Cat. No. DY406), TNF-α using the Mouse TNF-α DuoSet ELISA (R&D Systems, Cat. No. DY410), and CXCL1 using the Mouse CXCL1/KC DuoSet ELISA (R&D Systems, Cat. No. DY453) following manufacturer’s instructions. .. AR TIC LE IN PR ES S (R&D Systems, Cat. No. DY401), IL-18 using the Mouse IL-18 DuoSet ELISA (R&D Systems, Cat. No. DY7625), IL-6 using the Mouse IL-6 DuoSet ELISA (R&D Systems, Cat. No. DY406), CXCL1 using the Article Title: Sulfated polysaccharide prevents senescent adipocyte-driven osteonecrosis by stem cell fate reprogramming Article Snippet: Furthermore, to explore the molecular mechanisms by which SCS regulates MSCs lineage bias, bone marrow supernatant was collected on day 7 following co-treatment with SCS and MPS, and ELISA assays for IGF-1 (R&D Systems, MG100) and BMP-2 (R&D Systems, DBP200) were performed as described above. .. In addition, ELISA analyses of senescence-associated inflammatory factors (IL-1β, IL-18, TNF-α, CCL3 (Neobioscience, EMC010a.96), Clinical Proteomics:Article Title: A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload Article Snippet: .. Actinomycin D (1229, R&D Systems), Healthy human PBMCs (Precision Medicine), HEK Blue Reporter Assay IL23 (hkb-il23, InvivoGen), HEK Blue Reporter Assay IL12 (hkb-il12, InvivoGen), L929 (Sigma), human IL23 (1290-IL/CF, R&D Systems), cynomolgus IL12 (10215-CL, R&D systems), human neutrophil elastase (324681, Merck), human TNF-α (TNFA-HA4211, Acro Bioscience), Phytohemagglutinin-L (PHA) (11249738001, Sigma), QUANTI-Blue solution (rep-qbs, InvivoGen), tofacitinib (FT32555, Biosynth), WST-1 reagent (11644807001, Merck), mIL-6 (Quantikine ELISA, M6000B, R&D Systems), MCP-1 (Quantikine ELISA, JE00B, R&D Systems), and Reporter Assay:Article Title: A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload Article Snippet: .. Actinomycin D (1229, R&D Systems), Healthy human PBMCs (Precision Medicine), HEK Blue Reporter Assay IL23 (hkb-il23, InvivoGen), HEK Blue Reporter Assay IL12 (hkb-il12, InvivoGen), L929 (Sigma), human IL23 (1290-IL/CF, R&D Systems), cynomolgus IL12 (10215-CL, R&D systems), human neutrophil elastase (324681, Merck), human TNF-α (TNFA-HA4211, Acro Bioscience), Phytohemagglutinin-L (PHA) (11249738001, Sigma), QUANTI-Blue solution (rep-qbs, InvivoGen), tofacitinib (FT32555, Biosynth), WST-1 reagent (11644807001, Merck), mIL-6 (Quantikine ELISA, M6000B, R&D Systems), MCP-1 (Quantikine ELISA, JE00B, R&D Systems), and Sandwich ELISA:Article Title: Supplementation with endogenous healthy gut metabolites reverses the disruptions of in vitro and ex vivo epithelial functions induced by fecal content from IBD patients Article Snippet: Staining of fixed cells was performed using anti-ZO1 antibodies (Thermo Fisher 33-9100), DAPI Fluoromount G (SouthernBiotech 0100), and actin Phalloidin-iFluor 488 (Abcam ab176753). .. Article Title: Supplementation with endogenous healthy gut metabolites reverses the disruptions of in vitro and ex vivo epithelial functions induced by fecal content from IBD patients. Article Snippet: Staining of fixed cells was performed using anti-ZO1 antibodies (Thermo Fisher 33-9100), DAPI Fluoromount G (SouthernBiotech 0100), and actin Phalloidin-iFluor 488 (Abcam ab176753). .. |